(secondQuint)Randomized, Placebo-controlled, Multi-dose, Study Comparing Budesonide/Formoterol to Symbicort in Asthmatic Patients.

 This is a pivotal trial that will examine therapeutic equivalence of a new generic fixed-dose combination product containing Budesonide 80 mcg / Formoterol fumarate dihydrate 4.

5 mcg and reference listed drug (RLD) Symbicort(R) inhalation aerosol in adult patients with chronic but stable asthma as defined in National Asthma Education and Prevention Program Expert Panel Report 3 (NAEPP 3) guidelines.

 To ensure adequate study sensitivity the test and reference products should both be statistically superior to placebo (p<0.

05) with regard to the bioequivalent study primary endpoints.

.

 Randomized, Placebo-controlled, Multi-dose, Study Comparing Budesonide/Formoterol to Symbicort in Asthmatic Patients@highlight

A randomized multiple-dose, placebo-controlled, parallel group design consisting of a 2-week run-in period followed by a 6-week treatment period of the placebo, Test product (Budesonide 80 mcg / Formoterol fumarate dihydrate 4.

5 mcg), or Reference product Symbicort(R) inhalation aerosol.

